Publicaciones (184) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. Hints on the Lateralization of Dopamine Binding to D 1 Receptors in Rat Striatum

    Molecular Neurobiology, Vol. 53, Núm. 8, pp. 5436-5445

  2. A Long Noncoding RNA Regulates Sister Chromatid Cohesion

    Molecular Cell, Vol. 63, Núm. 3, pp. 397-407

  3. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer

    Molecular Oncology, Vol. 10, Núm. 9, pp. 1437-1449

  4. A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma

    Expert Opinion on Biological Therapy, Vol. 16, Núm. 5, pp. 627-643

  5. A novel epigenetic signature for early diagnosis in lung cancer

    Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371

  6. A simple and Efficient in Vivo non-viral RNA transfection method for labeling the whole axonal tree of individual adult long-range projection neurons

    Frontiers in Neuroanatomy, Vol. 10, Núm. MAR

  7. A versatile vector for in vivo monitoring of type I interferon induction and signaling

    PLoS ONE, Vol. 11, Núm. 3

  8. Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming

    Cancer Research, Vol. 76, Núm. 20, pp. 5994-6005

  9. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes

    Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 30-34

  10. Advanced assay monitoring APP-carboxyl-terminal fragments as markers of APP processing in Alzheimer disease mouse models

    Methods in Molecular Biology, Vol. 1303, pp. 117-123

  11. Analysis of SOX2-regulated transcriptome in glioma stem cells

    PLoS ONE, Vol. 11, Núm. 9

  12. Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma

    Cancer Investigation, Vol. 34, Núm. 1, pp. 39-44

  13. Are we closer to cardiac regeneration?

    Stem Cell Investigation, Vol. 2016, Núm. OCT

  14. Assessment of minimal residual disease in myeloma and the need for a consensus approach

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 21-25

  15. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism

    Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138

  16. Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization

    Frontiers in Pharmacology, Vol. 7, Núm. MAR

  17. Bioinformatics tools for the analysis of NMR metabolomics studies focused on the identification of clinically relevant biomarkers

    Briefings in Bioinformatics, Vol. 17, Núm. 3, pp. 541-552

  18. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

  19. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms

    Oncotarget, Vol. 7, Núm. 29, pp. 45060-45078

  20. Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

    Drugs, Vol. 76, Núm. 9, pp. 925-945